Search
Search
From R&D to QC, every lab faces the same reality. Analytical demands keep increasing, the number of samples continues to rise, and regulatory expectations continually evolve.
As these demands multiply, many labs will reach a breaking point where legacy instruments and operators can no longer keep up due to:
And despite these compounding issues, many labs are still hesitant to modernize old methods because of two major concerns: revalidation and compliance.
Modernizing routine methods does not automatically require full revalidation. The right approach depends on your goals, constraints, and regulatory strategy.
In practice, modernization can include:
With a controlled, step-by-step approach, labs can define validation scope, document changes, and maintain compliance with confidence.
Our case study, conducted at the Opella site in Compiègne, France, demonstrates how a controlled HPLC-to-UHPLC method modernization approach can sustainably transform routine analytical workflows.
“By dramatically reducing analytical time and minimizing solvent use, the Thermo Scientific Vanquish Flex UHPLC sets a new standard for efficiency, sustainability and safety in the lab.”
Xavier Lelièvre, Head of Quality at Opella Compiègne
Waiting to modernize your methods until absolutely necessary might seem justifiable in the short term. But in the long-run, outdated workflows, instruments, and software can introduce performance and compliance risks, eventually forcing change. Here’s how.
Aging systems increase downtime risk, create bottlenecks, and drive rising operating costs. As platforms age, service and parts availability may also decline, adding further strain on your operations.
At some point, modernization becomes forced. Staying proactive helps reduce risk and positions your lab for long-term efficiency, scalability, and compliance.
Start by identifying methods that create the greatest operational challenges. From there, two modernization paths are possible:
In practice, this type of optimization supports measurable gains in throughput and solvent reduction.
While more resource-intensive, the long-term benefits in productivity, robustness, sustainability, and operational confidence are well-suited for high-impact, high-volume methods.
Successful modernization requires a structured and thoughtful approach, and often includes an integrated solution across hardware, software, and workflows. Thermo Scientific has a complete portfolio of solutions that directly support method optimization, day-to-day laboratory efficiency and scalability.
Thermo Scientific Vanquish Flex UHPLC Systems are compatible with third-party CDS software and support straightforward and compliant method transfers under USP <621>.
“The Vanquish Flex UHPLC system is highly flexible, provides excellent injection repeatability, consistent results and therefore minimizing sample repetitions. Its intuitive design includes LED lights that clearly indicate the status of the equipment, making it user-friendly and efficient.”
Ana Laura Castillo (Chemical Analyst) and Andrés López (QC Coordinator) at Opella Ocoyoacac
Thermo Scientific Chromeleon CDS Enterprise helps provide regulated labs with a complete solution to maintain data integrity and meet 21 CFR Part 11 electronic signature requirements with confidence throughout the data lifecycle.
“Without the ease of access to the script command lines in Chromeleon CDS, we would not have been able to seamlessly integrate external systems into our analysis sequences.”
Salomé Soulier (Analytical Engineer) and Grégoire Mathieu (Senior Scientist) at Sanofi Sisteron France
Modernizing routine HPLC methods is not a one-size-fits-all process. To help you get started, we’ve put together a “Method Modernization Plan” with recommended products and workflow solutions for your routine lab.
| Vanquish Flex + Current CDS | Vanquish Flex + Chromeleon CDS Enterprise | Vanquish Flex Duo + Chromeleon CDS Enterprise | |
| UHPLC modernization | |||
| Workflow automation | — | ||
| Dual channel throughput | — | — |
Not necessarily. Frameworks such as ICH Q14, ICH Q2 (R2), and updates to USP <621> allow certain method adjustments without full revalidation, provided changes are scientifically justified and properly documented.
USP <621> allows defined adjustments to parameters such as column dimensions, flow rate, gradient conditions, or injection volume, if method performance equivalence is demonstrated.
For high-impact method changes, significant performance improvements to reduce testing failures, or when required by regulatory or internal quality standards.
For Research Use Only. Not for use in diagnostic procedures.